How innovation & technology are propelling molecular point-of-care testing: Insights from Memorial Hermann and Cue Health
Healthcare today is rapidly evolving to facilitate patient care that is decentralized, less fragmented and more competitive. To meet these demands, the industry has begun adopting point-of-care testing (POCT) for convenience and speed over lab-based testing.
To learn more about the state of POCT today, Becker's Hospital Review spoke with Rhonda Ashcraft, laboratory manager for clinical operations with Memorial Hermann Medical Group in Houston, and two leaders from Cue Health, an innovator in molecular point-of-care diagnostics.
This white paper contains insights on:
To learn more about the state of POCT today, Becker's Hospital Review spoke with Rhonda Ashcraft, laboratory manager for clinical operations with Memorial Hermann Medical Group in Houston, and two leaders from Cue Health, an innovator in molecular point-of-care diagnostics.
This white paper contains insights on:
- The evolution and limitations of antigen testing
- Traditional barriers to molecular POCT and how to overcome them
- Why molecular POCT is becoming the "gold standard" of POCT solutions
Please fill out the form to download the whitepaper.